Stockscreener 앱 받기
3.00
5.06%
-0.16
전일 마감가:
$3.16
열려 있는:
$3.16
하루 거래량:
173.72K
Relative Volume:
0.23
시가총액:
$6.81M
수익:
-
순이익/손실:
$-22.71M
주가수익비율:
-0.2562
EPS:
-11.71
순현금흐름:
$-18.24M
1주 성능:
-32.28%
1개월 성능:
-73.91%
6개월 성능:
-78.43%
1년 성능:
-94.74%
1일 변동 폭
$2.85
$3.16
1주일 범위
$2.85
$4.4886
52주 변동 폭
$2.85
$63.00
Genprex Inc Stock (GNPX) Company Profile
명칭
Genprex Inc
전화
512-537-7997
주소
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
GNPX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
3.00 | 7.17M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-01-26 | 개시 | National Securities | Buy |
| 2019-04-29 | 개시 | Noble Capital Markets | Outperform |
Genprex Inc 주식(GNPX)의 최신 뉴스
Genprex files prospectus supplement for up to $75 million at-the-market offering By Investing.com - Investing.com Australia
Genprex files prospectus supplement for up to $75 million at-the-market offering - Investing.com Australia
Genprex Announces $75 Million Stock Offering - TipRanks
Genprex, Inc. Announces $75 Million Stock Offering - TradingView
Can Genprex Inc. (2DE0) stock sustain revenue momentumWeekly Stock Summary & Safe Swing Trade Setup Alerts - newser.com
How Genprex Inc. stock benefits from tech adoption2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
Is Genprex Inc. stock attractive for retirement portfoliosJuly 2025 Breakouts & High Conviction Trade Alerts - newser.com
Genprex Inc. (GNPX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Genprex Inc. (2DE0) stock attracts wealthy investorsPortfolio Gains Summary & Fast Gain Swing Trade Alerts - newser.com
Is Genprex Inc. (2DE0) stock at risk of policy regulationWeekly Profit Report & Expert Approved Momentum Trade Ideas - newser.com
Will Genprex Inc. (2DE0) stock outperform global peersJuly 2025 Gainers & Consistent Growth Equity Picks - newser.com
Published on: 2025-11-19 22:26:30 - newser.com
Is Genprex Inc. (2DE0) stock undervalued at current priceWeekly Profit Analysis & Growth Focused Investment Plans - newser.com
Can Genprex Inc. (2DE0) stock reach $200 price targetJuly 2025 Retail & Short-Term Trading Alerts - newser.com
Will Genprex Inc. stock reach Wall Street targets2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
Will Genprex Inc. (2DE0) stock remain on Wall Street radarBull Run & Real-Time Chart Breakout Alerts - newser.com
Published on: 2025-11-19 13:34:52 - newser.com
Can Genprex Inc. (2DE0) stock beat analyst consensusEntry Point & Free Verified High Yield Trade Plans - newser.com
MSN Money - MSN
Genprex Expands Clinical Trials with New Site Addition - TipRanks
Genprex Expands Clinical Trials for Lung Cancer Therapy - TradingView
[8-K] Genprex, Inc. Reports Material Event | GNPX SEC FilingForm 8-K - Stock Titan
Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lung Cancer Clinical Trials - PR Newswire
Can Genprex Inc. (2DE0) stock ride next bull market cycleJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com
Is Genprex Inc. (2DE0) stock a top pick for value investors2025 EndofYear Setup & Safe Capital Investment Plans - newser.com
Can technical indicators confirm Genprex Inc.’s reversalEarnings Recap Report & Weekly Watchlist for Consistent Profits - newser.com
Why Genprex Inc. stock remains a top recommendationMarket Risk Analysis & Real-Time Volume Trigger Notifications - newser.com
Analyzing drawdowns of Genprex Inc. with statistical toolsIPO Watch & Entry Point Strategy Guides - newser.com
Genprex Inc (GNPX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):